Search for: "Tom Lamb" Results 221 - 240 of 1,048
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Aug 2008, 9:50 pm
Most Of These Product Liability Cases Allege Fosamax Caused Drug-Induced Osteonecrosis Of The Jaw (ONJ) (Posted by Tom Lamb at DrugInjuryWatch.com) According to an August 14, 2008 "MERCK & CO: Faces 655 Product Liability Cases Over Fosamax Drug", published by Lloyds Corporate Litigation Reporter:   Merck & Co., Inc., as of June 30, 2008, faced approximately 655  product liability cases involving Fosamax drug, including about… [read post]
22 May 2009, 11:24 am
Agency Has Received Case Reports Of Hepatotoxicity For Orlistat, The Active Ingredient For Xenical And Alli (Posted by Tom Lamb at DrugInjuryWatch.com) There was only this brief mention in the Memorandum of Meeting Minutes for the FDA's April 16, 2009 Drug Safety Oversight Board Meeting: The Drug Safety Oversight Board (DSB) discussed two topics: the product orlistat and the potential risk of hepatotoxicity and alcohol-based skin antiseptics and the risk of a fire in the… [read post]
19 Jun 2009, 12:29 pm
Doctors Should Inform Their Patients About Potential Serious Side Effects Like Osteonecrosis Of The Jaw And Femur Fractures (Posted by Tom Lamb at DrugInjuryWatch.com) The rather alerting headline above comes from an article, "Osteoporosis treatments and adverse events", which was published in the April 30, 2009 edition of Current Opinion in Rheumatology. [read post]
2 Sep 2009, 11:46 am
August 2009 Medical Journal Article Presents Well-Documented Report Of Pancreatitis In Context Of Byetta Use (Posted by Tom Lamb at DrugInjuryWatch.com) In October 2007 the FDA announced that the agency had reviewed 30 postmarketing reports of acute pancreatitis in patients taking Byetta (exenatide), a drug used to treat adults with type 2 diabetes. [read post]
20 Aug 2008, 8:04 pm
Various Parties Have Filed Briefs  With Their  Arguments About Whether  Or Not  An Injured Patient Should Be Able To File A  Lawsuit Against  The Drug Company (Posted by Tom Lamb at DrugInjuryWatch.com) As some of you are aware by now, this fall the Supreme Court will hear oral arguments in the case Wyeth v. [read post]
30 Dec 2010, 11:30 am by Tom Lamb
SJS And TEN Differ In The Extent Of Skin Detachment, But Both Are Severe And Life-Threatening Drug Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) Stevens-Johnson syndrome (SJS) was first described in 1922, and toxic epidermal necrolysis (TEN) was first described in 1956. [read post]
18 Mar 2009, 11:56 am
Risk Is Greatest For Elderly, Especially Older Women, And Long-Term Users Of This Popular Gastrointestinal Medication (Posted by Tom Lamb at DrugInjuryWatch.com) On February 26, 2009 the FDA sent by email a MedWatch Alert, "Metoclopramide-containing drugs: chronic use linked to tardive dyskinesia", which included this information: FDA notified healthcare professionals that manufacturers of metoclopramide, a drug used to treat gastrointestinal disorders, must add a… [read post]
26 Apr 2007, 2:58 pm
Findings Of April 2007 AHRQ Report On Side Effects And Other Medication Problems In American Hospitals (Posted by Tom Lamb at DrugInjuryWatch.com) A recent online article provided a summary of the findings from the "Adverse Drug Events in U.S. [read post]
6 Sep 2007, 2:56 pm
Antibiotic Ketek Restricted To Certain Types Of Pneumonia; No Longer Used For Sinusitis, Bronchitis, Tonsillitis, Pharyngitis (Posted by Tom Lamb at DrugInjuryWatch.com) On September 5, 2007 Health Canada issued by email a MedEffect alert about Ketek which included this summary:Sanofi-aventis Canada, Inc. is informing Canadians that the antibiotic Ketek (telithromycin), should no longer be used to treat sinusitis, bronchitis, tonsillitis or pharyngitis. [read post]
10 May 2007, 7:41 am
(Posted by Tom Lamb at DrugInjuryWatch.com) Natrecor (nesiritide) is approved for the treatment of patients with acutely decompensated heart failure who suffer from symptoms at rest or with minimal exertion. [read post]
3 Mar 2011, 12:58 pm by Tom Lamb
Adverse Reactions And Warnings Sections Now Include Hepatotoxicity, From Hepatic Dysfunction To Liver Failure  (Posted by Tom Lamb at DrugInjuryWatch.com) The association between the antibiotic Zithromax (azithromycin) and drug-induced liver failure first received some real attention in 2010. [read post]
29 Dec 2011, 11:02 am by Tom Lamb
Three More Lawsuits (Boles, Jellema, and Spano) Set For Trial, And A Special Master Appointed To Conduct Settlement Talks (Posted by Tom Lamb at DrugInjuryWatch.com) There are currently more than 900 Fosamax lawsuits pending against defendant Merck Sharp & Dohme Corp. [read post]
18 Aug 2009, 11:32 am
Recent Studies Find That New Progestin Drospirenone Has 1.7 Times Increased Risk Of Developing Blood Clots Compared To Levonorgestrel (Posted by Tom Lamb at DrugInjuryWatch.com) Let's start with an August 13, 2009 MedPage Today article, "Thrombosis Risk with OCs Depends on Progestogen", from which we get this concise summary of the issue from Nick Dunn, MD, of the University of Southampton: All of the more recent progestogens, possibly except norgestimate, now… [read post]
2 Jan 2008, 9:12 am
Sanofi-Aventis Antibiotic Has Been Subject Of Controversy Since Reports of Liver Damage Surfaced In Early 2006 (Posted by Tom Lamb at DrugInjuryWatch.com) The safety concerns about Ketek (telithromycin) began in early 2006 after Health Canada and the European Union's European Medicines Agency (EMEA) issued alerts based on the online "early" release of an article about Ketek that would later be published in the March 21, 2006 edition of the Annals of… [read post]
23 Feb 2011, 2:48 pm by Tom Lamb
Long-Term Bisphosphonate Use Linked To Subtrochanteric And Femoral Shaft Fractures, Also Called Femur Fractures (Posted by Tom Lamb at DrugInjuryWatch.com) An article published in the February 23, 2011 edition of the medical journal JAMA (Journal of the American Medical Association) reports on research finding that older women who used Fosamax, Boniva, Reclast, or other bisphosphonate drugs had a significant increased risk of suffering leg fractures involving their thigh… [read post]
29 Jan 2008, 3:13 pm
Congress Wants To Know When Sanofi-Aventis And The FDA Learned About Fraud Involved With Ketek Study 3014 (Posted by Tom Lamb at DrugInjuryWatch.com) Soon after noon on January 29, 2008 Ed Silverman posted on his Pharmalot blog an article, "House Committee Will Subpoena FDA Over Ketek", which reported this breaking news about the Congressional investigation into Ketek, Sanofi-Aventis, and the FDA:At its hearing this morning, the House Energy and Commerce… [read post]